These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 12428809)

  • 41. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
    Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
    Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
    Gallardo G; Holtzman DM
    Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of functional circuitry in aging brain and the impact of mutated APP expression.
    Bearer EL; Manifold-Wheeler BC; Medina CS; Gonzales AG; Chaves FL; Jacobs RE
    Neurobiol Aging; 2018 Oct; 70():276-290. PubMed ID: 30055413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
    Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
    J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.
    Zhao H; Chang R; Che H; Wang J; Yang L; Fang W; Xia Y; Li N; Ma Q; Wang X
    Neurosci Lett; 2013 Sep; 551():12-6. PubMed ID: 23810804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
    Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
    J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
    Cole AR; Noble W; van Aalten L; Plattner F; Meimaridou R; Hogan D; Taylor M; LaFrancois J; Gunn-Moore F; Verkhratsky A; Oddo S; LaFerla F; Giese KP; Dineley KT; Duff K; Richardson JC; Yan SD; Hanger DP; Allan SM; Sutherland C
    J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.
    Muyllaert D; Terwel D; Borghgraef P; Devijver H; Dewachter I; Van Leuven F
    Rev Neurol (Paris); 2006 Oct; 162(10):903-7. PubMed ID: 17028556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.
    Obulesu M; Venu R; Somashekhar R
    Neurochem Res; 2011 Aug; 36(8):1329-35. PubMed ID: 21509508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tau aggregation is a therapeutic target for Alzheimer's disease.
    Takashima A
    Curr Alzheimer Res; 2010 Dec; 7(8):665-9. PubMed ID: 20678070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.
    Ubhi K; Rockenstein E; Doppler E; Mante M; Adame A; Patrick C; Trejo M; Crews L; Paulino A; Moessler H; Masliah E
    Acta Neuropathol; 2009 Jun; 117(6):699-712. PubMed ID: 19252918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration.
    Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH
    Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport.
    Torroja L; Chu H; Kotovsky I; White K
    Curr Biol; 1999 May; 9(9):489-92. PubMed ID: 10322116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation.
    Giovinazzo D; Bursac B; Sbodio JI; Nalluru S; Vignane T; Snowman AM; Albacarys LM; Sedlak TW; Torregrossa R; Whiteman M; Filipovic MR; Snyder SH; Paul BD
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33431651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.
    Dawson HN; Cantillana V; Jansen M; Wang H; Vitek MP; Wilcock DM; Lynch JR; Laskowitz DT
    Neuroscience; 2010 Aug; 169(1):516-31. PubMed ID: 20434528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease.
    Iqbal K; Gong CX; Liu F
    Expert Opin Ther Targets; 2014 Mar; 18(3):307-18. PubMed ID: 24387228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.